One Charles Private Wealth Services’s Intensity Therapeutics INTS Stock Holding History

One Charles Private Wealth Services’s Portfolio INTS Stock Details INTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,272	Closed	-$13K	–	170
2025 Q4	$13K	Hold	1,272	–	–	﹤0.01%	171
2025 Q3	$7.72K	Hold	1,272	–	–	﹤0.01%	167
2025 Q2	$9.8K	Hold	1,272	–	–	﹤0.01%	163
2025 Q1	$62.6K	Hold	1,272	–	–	0.02%	144
2024 Q4	$56K	Hold	1,272	–	–	0.02%	153
2024 Q3	$121K	Hold	1,272	–	–	0.05%	150
2024 Q2	$156K	Hold	1,272	–	–	0.06%	146
2024 Q1	$165K	Buy	+1,272	New	+$152K	0.07%	142

Other funds holding INTS

Kingsbury Capital Investment Advisors Wilmette, Illinois $106M AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Sentinus LLC Oak Brook, Illinois $1.25B AUM 22.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mesirow Financial Investment Management Chicago, Illinois $6.47B AUM 15.41% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

One Charles Private Wealth Services's INTS Position: Q1 2026 in Review

One Charles Private Wealth Services sold out of Intensity Therapeutics (INTS) in Q1 2026, closing a stake of 1,272 shares — an estimated $13K sold.

One Charles Private Wealth Services first reported a position in INTS in Q1 2024 and held it in 8 quarters. The position peaked at $165K in Q1 2024. 14 funds tracked by Wall St. Rank hold INTS as of Q1 2026.

One Charles Private Wealth Services reported no remaining Intensity Therapeutics position as of Q1 2026 after selling out during the quarter.
One Charles Private Wealth Services sold 1,272 Intensity Therapeutics shares in Q1 2026, an estimated $13K.
One Charles Private Wealth Services first reported a position in Intensity Therapeutics in Q1 2024 and held it in 8 quarters.
One Charles Private Wealth Services's Intensity Therapeutics position peaked at $165K in Q1 2024.
14 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q1 2026.

Based on One Charles Private Wealth Services's 13F filing for Q1 2026, filed 7 May 2026.